34 results
8-K
EX-10.1
CNSP
Cns Pharmaceuticals Inc
14 Jun 24
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
5:25pm
. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s relationship with the Company
8-K
EX-10.1
ul5y7m
2 Feb 24
Entry into a Material Definitive Agreement
5:00pm
424B4
3mr4ytcg80
31 Jan 24
Prospectus supplement with pricing info
4:27pm
8-K
EX-10.2
dovut3bzkases8m6
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.1
6aeddwxs7dm8cvua
1 Dec 22
CNS Pharmaceuticals Announces Pricing of $6.0 Million Public Offering At a Premium to the Market Closing Price
5:19pm
8-K
EX-10.1
er5u 1mnqeam5t9mmvj
6 Jan 22
CNS Pharmaceuticals Announces $11.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
9:11am
8-K
EX-1.1
3aqcw7sxk1 2vl6c30
12 Feb 21
Entry into a Material Definitive Agreement
5:13pm